Risk of venous thromboembolism in association with factor V leiden in cancer patients – The EDITH case-control study

BACKGROUND: Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation. The impact of the factor V Leiden on the risk of VTE in cancer patients remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Heraudeau, Adeline, Delluc, Aurélien, Le Henaff, Mickaël, Lacut, Karine, Leroyer, Christophe, Desrues, Benoit, Couturaud, Francis, Tromeur, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959061/
https://www.ncbi.nlm.nih.gov/pubmed/29775482
http://dx.doi.org/10.1371/journal.pone.0194973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959061/
https://www.ncbi.nlm.nih.gov/pubmed/29775482
http://dx.doi.org/10.1371/journal.pone.0194973

Ejemplares similares